{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:57Z","timestamp":1786118997512,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,27]]},"DOI":"10.1097\/tp.0b013e3181837585","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T03:20:52Z","timestamp":1221621652000},"page":"791-796","source":"Crossref","is-referenced-by-count":67,"title":["Posaconazole as Salvage Therapy in Patients With Invasive Fungal Infections After Solid Organ Transplant"],"prefix":"10.1097","volume":"86","author":[{"given":"Barbara D.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Tob\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Hardalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Graybill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00001432-200312000-00015","article-title":"Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients.","volume":"16","author":"Nucci","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0891-5520(02)00067-3","article-title":"Fungal infections in the recipients of solid organ transplantation.","volume":"17","author":"Singh","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/109629603322419607","article-title":"Fungal infections in solid organ transplant patients.","volume":"4","author":"Hagerty","year":"2003","journal-title":"Surg Infect"},{"key":"R4-8-20210129","first-page":"483","article-title":"Transplant infections.","author":"Munoz","year":"2006"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/ajhp\/62.suppl_1.S17","article-title":"Overview of transplant mycology.","volume":"62","author":"Golan","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi.","volume":"37","author":"Husain","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200201150-00011","article-title":"Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplantation practices.","volume":"73","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/13543784.9.8.1797","article-title":"New investigational antifungal agents for treating invasive fungal infections.","volume":"9","author":"Hossain","year":"2000","journal-title":"Exp Opin Invest Drugs"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005792-200209000-00001","article-title":"Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature.","volume":"81","author":"Castiglioni","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/AAC.41.12.2714","article-title":"Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.","volume":"41","author":"Vandewoude","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience.","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1086\/429335","article-title":"Study of renal safety in amphotericin B lipid complex-treated patients.","volume":"40","author":"Alexander","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1523-1755.2005.00558.x","article-title":"Posttransplantation chronic renal damage in nonrenal transplant recipients.","volume":"68","author":"Stratta","year":"2005","journal-title":"Kidney Int"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1368-5031.2004.00167.x","article-title":"Posaconazole: A potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.","volume":"58","author":"Herbrecht","year":"2004","journal-title":"Int J Clin Pract"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2165\/00003495-200565110-00007","article-title":"Posaconazole.","volume":"11","author":"Keating","year":"2005","journal-title":"Drugs"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/503425","article-title":"Posaconazole as salvage treatment of invasive fusariosis in patients with underlying hematologic malignancy and other conditions.","volume":"42","author":"Raad","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases.","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/AAC.47.9.2788-2795.2003","article-title":"Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults.","volume":"47","author":"Courtney","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-200544020-00006","article-title":"Oral bioavailability of posaconazole in fasted healthy subjects: Comparison between three regimens and basis for clinical dosage recommendations.","volume":"44","author":"Ezzet","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/AAC.50.5.1881-1883.2006","article-title":"Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers.","volume":"50","author":"Sansone-Parsons","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejps.2004.01.005","article-title":"Effect of posaconazole on cytochrome P450 enzymes: A randomized, open-label, two-way crossover study.","volume":"21","author":"Wexler","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus.","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial.","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis.","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.healun.2003.09.033","article-title":"Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient.","volume":"23","author":"Herbrecht","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13693780400011104","article-title":"Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.","volume":"43","author":"Al-Abdely","year":"2005","journal-title":"Med Mycol"},{"key":"R30-8-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients.","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.tp.0000173771.47698.7b","article-title":"Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.","volume":"80","author":"Alexander","year":"2005","journal-title":"Transplantation"},{"key":"R32-8-20210129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1592\/phco.27.6.825","article-title":"Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.","volume":"27","author":"Sansone-Parsons","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R33-8-20210129","article-title":"NOXAFIL\u00ae (posaconazole) oral suspension.","year":"2006"},{"key":"R34-8-20210129","article-title":"Noxafil (posaconazole) 40 mg\/ml oral suspension [Summary of Product Characteristics].","author":"Europe","year":"2006"},{"key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1086\/504328","article-title":"Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.","volume":"42","author":"Raad","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R36-8-20210129","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/AAC.48.9.3543-3551.2004","article-title":"Disposition of posaconazole following single-dose oral administration in healthy subjects.","volume":"48","author":"Krieter","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-8-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0091270004271402","article-title":"Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease.","volume":"45","author":"Courtney","year":"2005","journal-title":"J Clin Pharmacol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181837585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:09:34Z","timestamp":1786036174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200809270-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,27]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181837585","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9,27]]}}}